Home
About
Overview
Sharing Data
ORCID
Help
History (1)
MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer.
MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer. Oncogene. 2022 07; 41(31):3859-3875.
View in:
PubMed
subject areas
Animals
Cell Line, Tumor
Histone Deacetylases
Mitosis
Paclitaxel
Pancreatic Neoplasms
authors with profiles
Pankaj Kumar Singh